Valuation check: 4889.T's profit margin is -461.59%, below the sector sector average of 13.23%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for 4889.T is -461.59% as of June 2026. That compares with 60.81% in the prior-year period — down 859.0% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside Renascience's historical trend and sector peers before judging valuation or financial health.
Over the past year, 4889.T's profit margin moved from 60.81% to -461.59% — a 859.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Renascience's valuation or profitability profile.
Against its sector companies, 4889.T currently prints -461.59% for profit margin, while the sector average sits near 13.23%. That is roughly 3590.0% below the sector mean. Large gaps often invite a closer look at Renascience's growth, margins, and balance sheet.
Profit Margin shows how effectively Renascience converts resources into returns. At -461.59%, 4889.T may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 60.81% in the prior-year period — down 859.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting 4889.T's profit margin (-461.59%), review year-over-year change from 60.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.